These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8977229)

  • 1. Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway.
    Sun Y; Pinchuk LM; Agy MB; Clark EA
    J Immunol; 1997 Jan; 158(1):512-7. PubMed ID: 8977229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex.
    Siefken R; Kurrle R; Schwinzer R
    Cell Immunol; 1997 Feb; 176(1):59-65. PubMed ID: 9070318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat.
    Tong-Starkesen SE; Luciw PA; Peterlin BM
    J Immunol; 1989 Jan; 142(2):702-7. PubMed ID: 2536062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis.
    Blotta MH; Marshall JD; DeKruyff RH; Umetsu DT
    J Immunol; 1996 May; 156(9):3133-40. PubMed ID: 8617933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-mitogenic T cell activation signals are sufficient for induction of human immunodeficiency virus transcription.
    Gruters RA; Otto SA; Al BJ; Verhoeven AJ; Verweij CL; Van Lier RA; Miedema F
    Eur J Immunol; 1991 Jan; 21(1):167-72. PubMed ID: 1846814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A.
    van der Pouw Kraan TC; Boeije LC; Troon JT; Rutschmann SK; Wijdenes J; Aarden LA
    J Immunol; 1996 Mar; 156(5):1818-23. PubMed ID: 8596032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CD28/CD3-mediated costimulation of naive and memory human T lymphocytes by intracellular incorporation of polyclonal antibodies specific for the activator protein-1 transcriptional complex.
    Woodside DG; McIntyre BW
    J Immunol; 1998 Jul; 161(2):649-58. PubMed ID: 9670939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CD28-associated signaling pathway leading to cytokine gene transcription and T cell proliferation without TCR engagement.
    Siefken R; Klein-Hessling S; Serfling E; Kurrle R; Schwinzer R
    J Immunol; 1998 Aug; 161(4):1645-51. PubMed ID: 9712026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles.
    Chapman A; Stewart SJ; Nepom GT; Green WF; Crowe D; Thomas JW; Miller GG
    J Immunol; 1996 Dec; 157(11):4771-80. PubMed ID: 8943378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
    Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
    Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosslinking of CD27 in the presence of CD28 costimulation results in T cell proliferation and cytokine production.
    Sunder-Plassmann R; Pickl WF; Majdic O; Knapp W; Holter W
    Cell Immunol; 1995 Aug; 164(1):20-7. PubMed ID: 7634349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in responsiveness to CD3 stimulation between naive and memory CD4+ T cells cannot be overcome by CD28 costimulation.
    Kuiper H; Brouwer M; de Boer M; Parren P; van Lier RA
    Eur J Immunol; 1994 Sep; 24(9):1956-60. PubMed ID: 7522154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 costimulation promotes the production of Th2 cytokines.
    Rulifson IC; Sperling AI; Fields PE; Fitch FW; Bluestone JA
    J Immunol; 1997 Jan; 158(2):658-65. PubMed ID: 8992981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.